Related Experiment Video
Updated: Jun 14, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)
Published on: November 27, 2019
Standardized effect sizes are far from "Standardized": A primer and empirical illustration in depression
Mathias Harrer1,2, Clara Miguel1, Yan Luo3
1Department of Clinical, Neuro and Developmental Psychology, World Health Organization Collaborating Center for Research and Dissemination of Psychological Interventions, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands.
Abstract:
Standardized mean differences (SMDs) are frequently used to appraise the effects of psychological treatments, and to combine them in meta-analyses. Yet, there is no consensus on how exactly SMDs should be computed from randomized trials. In this study, we show that different SMD variants can heavily diverge in aggregate-data meta-analyses, subverting the original purpose of standardization. We investigate the impact this has on the estimated benefits of depression psychotherapies. Different SMD versions using endpoint or change scores were calculated from a comprehensive database of randomized trials, comparing depression psychotherapy against pharmacotherapy and inactive controls. Pooled treatment effects were obtained for each variant, assuming correlations between baseline and endpoint scores of 0.2 through 0.8, and their relationship was examined using bivariate meta-analyses. We also investigated which study characteristics predicted divergent effect estimates. A total of k = 443 trials with 48,221 participants were analyzed. The pooled effect of psychotherapy versus controls varied heavily depending on the calculation methods (SMD = 0.65-1.24), even though the same studies were used. Divergences were less pronounced for psychotherapies compared to pharmacotherapy (SMD = 0.05-0.14). Change score SMDs deviated from endpoint SMDs especially when high (r = 0.8) or low (r = 0.2) pre-post correlations were assumed. This difference was largest in subfields with high treatment effects. Different SMD calculation methods can lead to strongly diverging effect estimates of psychological treatment; especially when change scores are used and pre-post correlations are very high or low. This could have a profound impact on how treatment benefits are interpreted within and across meta-analyses. Researchers could prioritize endpoint SMDs of randomized trials, and should consider standardization using population-level estimates to improve the comparability of meta-analytic effects in the field. Open Material; Registration: htpps://doi.org/10.5281/zenodo.10694719; https://osf.io/yx5jg; https://osf.io/4j23t.
More Related Videos
Related Concept Videos
The Placebo Effect
Regression Toward the Mean
Depression: Overview
Antidepressant Drugs: MAOIs and Other Agents
Elements Crucial for Effective Psychotherapy
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...

